Dr. Adam Seth Bodzin, MD

Dr. Bodzin practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Bodzin's NPI, 1366651416, was assigned on May 22, 2007. Dr. Bodzin graduated from Boston University School Of Medicine in 2007. Dr. Bodzin holds Pennsylvania license MD440817.

Dr. Bodzin's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Dr. Bodzin's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Bodzin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bodzin practices, 2 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Bodzin's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Bodzin is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Bodzin's licenses on file in 4 states: Pennsylvania, California, Delaware and Illinois.

Dmand AI lists kidney transplant among the conditions Dr. Bodzin treats.

CMS data shows 73 Medicare services from Dr. Bodzin across 1 procedure code in 2024, for 51 Medicare patients. Medicare paid $4,629 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 51 Medicare patients who saw Dr. Bodzin in 2024. The largest group is under 65, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 4.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bodzin's median patient age at 55, with 44% women.

In 2024, Dr. Bodzin wrote 272 Medicare Part D claims for 23 patients. 92% of them were for generic drugs. CMS names the drug for 146 of them, across 7 drugs with 11 or more claims each, at $22,624 in total drug cost. In 2023, CMS named 186 claims across 9 drugs.

Dr. Bodzin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 42 papers to Dr. Bodzin, published from 2010 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Liver Transplantation, Graft Survival and Carcinoma, Hepatocellular. Dr. Bodzin has published most often in Liver Transpl. Dr. Bodzin's most frequent co-authors are Adam M. Frank, MD, Ashesh Piyush Shah, MD and Warren R. Maley, MD.

CMS Open Payments shows 51 general payments to Dr. Bodzin from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. TransMedics, Inc. paid the most, $71,353. It also lists 14 research payments totaling $60,610 from 2019 to 2020.

Dr. Bodzin graduated from Boston University School Of Medicine in 2007.

Dr. Bodzin is in network with 19 carriers, including Aetna, Highmark and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.